These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12459592)

  • 61. The partitioning of TCR repertoires by thymic selection.
    Lo WL; Huseby ES
    J Exp Med; 2024 Oct; 221(10):. PubMed ID: 39167074
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Defining the balance between optimal immunity and immunopathology in influenza virus infection.
    Nguyen THO; Rowntree LC; Chua BY; Thwaites RS; Kedzierska K
    Nat Rev Immunol; 2024 Oct; 24(10):720-735. PubMed ID: 38698083
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CD8
    Menon T; Illing PT; Chaurasia P; McQuilten HA; Shepherd C; Rowntree LC; Petersen J; Littler DR; Khuu G; Huang Z; Allen LF; Rockman S; Crowe J; Flanagan KL; Wakim LM; Nguyen THO; Mifsud NA; Rossjohn J; Purcell AW; van de Sandt CE; Kedzierska K
    Nat Commun; 2024 Apr; 15(1):3387. PubMed ID: 38684663
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prior infection with unrelated neurotropic virus exacerbates influenza disease and impairs lung T cell responses.
    Foo IJ; Chua BY; Clemens EB; Chang SY; Jia X; McQuilten HA; Yap AHY; Cabug AF; Ashayeripanah M; McWilliam HEG; Villadangos JA; Evrard M; Mackay LK; Wakim LM; Fazakerley JK; Kedzierska K; Kedzierski L
    Nat Commun; 2024 Mar; 15(1):2619. PubMed ID: 38521764
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genetic fusion of CCL11 to antigens enhances antigenicity in nucleic acid vaccines and eradicates tumor mass through optimizing T-cell response.
    Qi H; Sun Z; Gao T; Yao Y; Wang Y; Li W; Wang X; Wang X; Liu D; Jiang JD
    Mol Cancer; 2024 Mar; 23(1):46. PubMed ID: 38459592
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common
    Lim WC; Marques Da Costa ME; Godefroy K; Jacquet E; Gragert L; Rondof W; Marchais A; Nhiri N; Dalfovo D; Viard M; Labaied N; Khan AM; Dessen P; Romanel A; Pasqualini C; Schleiermacher G; Carrington M; Zitvogel L; Scoazec JY; Geoerger B; Salmon J
    Front Immunol; 2023; 14():1265469. PubMed ID: 38318504
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection.
    Vecchio E; Rotundo S; Veneziano C; Abatino A; Aversa I; Gallo R; Giordano C; Serapide F; Fusco P; Viglietto G; Cuda G; Costanzo F; Russo A; Trecarichi EM; Torti C; Palmieri C
    J Transl Med; 2024 Jan; 22(1):33. PubMed ID: 38185632
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Newborn and child-like molecular signatures in older adults stem from TCR shifts across human lifespan.
    van de Sandt CE; Nguyen THO; Gherardin NA; Crawford JC; Samir J; Minervina AA; Pogorelyy MV; Rizzetto S; Szeto C; Kaur J; Ranson N; Sonda S; Harper A; Redmond SJ; McQuilten HA; Menon T; Sant S; Jia X; Pedrina K; Karapanagiotidis T; Cain N; Nicholson S; Chen Z; Lim R; Clemens EB; Eltahla A; La Gruta NL; Crowe J; Lappas M; Rossjohn J; Godfrey DI; Thomas PG; Gras S; Flanagan KL; Luciani F; Kedzierska K
    Nat Immunol; 2023 Nov; 24(11):1890-1907. PubMed ID: 37749325
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The germline HLA-A02B62 supertype is associated with a PD-L1-positive tumour immune microenvironment and poor prognosis in stage I lung cancer.
    Lin R; Chen X; Su F; Wang H; Han B; Chen Y; Zhang C; Ma M
    Heliyon; 2023 Aug; 9(8):e18948. PubMed ID: 37600368
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency.
    Heitmann JS; Tandler C; Marconato M; Nelde A; Habibzada T; Rittig SM; Tegeler CM; Maringer Y; Jaeger SU; Denk M; Richter M; Oezbek MT; Wiesmüller KH; Bauer J; Rieth J; Wacker M; Schroeder SM; Hoenisch Gravel N; Scheid J; Märklin M; Henrich A; Klimovich B; Clar KL; Lutz M; Holzmayer S; Hörber S; Peter A; Meisner C; Fischer I; Löffler MW; Peuker CA; Habringer S; Goetze TO; Jäger E; Rammensee HG; Salih HR; Walz JS
    Nat Commun; 2023 Aug; 14(1):5032. PubMed ID: 37596280
    [TBL] [Abstract][Full Text] [Related]  

  • 71. T cell repertoire breadth is associated with the number of acute respiratory infections in the LoewenKIDS birth cohort.
    Paschold L; Gottschick C; Langer S; Klee B; Diexer S; Aksentijevich I; Schultheiß C; Purschke O; Riese P; Trittel S; Haase R; Dressler F; Eberl W; Hübner J; Strowig T; Guzman CA; Mikolajczyk R; Binder M
    Sci Rep; 2023 Jun; 13(1):9516. PubMed ID: 37308563
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Architecture of the SARS-CoV-2-specific T cell repertoire.
    Zornikova KV; Sheetikov SA; Rusinov AY; Iskhakov RN; Bogolyubova AV
    Front Immunol; 2023; 14():1070077. PubMed ID: 37020560
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Homologous peptides derived from influenza A, B and C viruses induce variable CD8
    Nguyen AT; Lau HMP; Sloane H; Jayasinghe D; Mifsud NA; Chatzileontiadou DS; Grant EJ; Szeto C; Gras S
    Clin Transl Immunology; 2022; 11(10):e1422. PubMed ID: 36275878
    [TBL] [Abstract][Full Text] [Related]  

  • 74. SARS-CoV-2-specific T cell memory with common TCRαβ motifs is established in unvaccinated children who seroconvert after infection.
    Rowntree LC; Nguyen THO; Kedzierski L; Neeland MR; Petersen J; Crawford JC; Allen LF; Clemens EB; Chua B; McQuilten HA; Minervina AA; Pogorelyy MV; Chaurasia P; Tan HX; Wheatley AK; Jia X; Amanat F; Krammer F; Allen EK; Sonda S; Flanagan KL; Jumarang J; Pannaraj PS; Licciardi PV; Kent SJ; Bond KA; Williamson DA; Rossjohn J; Thomas PG; Tosif S; Crawford NW; van de Sandt CE; Kedzierska K
    Immunity; 2022 Jul; 55(7):1299-1315.e4. PubMed ID: 35750048
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Adaptive Immune Responses, Immune Escape and Immune-Mediated Pathogenesis during HDV Infection.
    Oberhardt V; Hofmann M; Thimme R; Neumann-Haefelin C
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215790
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity.
    Heitmann JS; Bilich T; Tandler C; Nelde A; Maringer Y; Marconato M; Reusch J; Jäger S; Denk M; Richter M; Anton L; Weber LM; Roerden M; Bauer J; Rieth J; Wacker M; Hörber S; Peter A; Meisner C; Fischer I; Löffler MW; Karbach J; Jäger E; Klein R; Rammensee HG; Salih HR; Walz JS
    Nature; 2022 Jan; 601(7894):617-622. PubMed ID: 34814158
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Neoantigen Controversies.
    Castro A; Zanetti M; Carter H
    Annu Rev Biomed Data Sci; 2021 Jul; 4():227-253. PubMed ID: 34465181
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Influence of HLA Class II Polymorphism on Predicted Cellular Immunity Against SARS-CoV-2 at the Population and Individual Level.
    Copley HC; Gragert L; Leach AR; Kosmoliaptsis V
    Front Immunol; 2021; 12():669357. PubMed ID: 34349756
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.
    Mahajan S; Kode V; Bhojak K; Karunakaran C; Lee K; Manoharan M; Ramesh A; Hv S; Srivastava A; Sathian R; Khan T; Kumar P; Gupta R; Chakraborty P; Chaudhuri A
    Sci Rep; 2021 Jun; 11(1):13164. PubMed ID: 34162945
    [TBL] [Abstract][Full Text] [Related]  

  • 80. SARS-CoV-2-specific CD8
    Rowntree LC; Petersen J; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Wheatley AK; Kent SJ; Rossjohn J; Kedzierska K; Nguyen TH
    Immunol Cell Biol; 2021 Oct; 99(9):990-1000. PubMed ID: 34086357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.